BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 0.1% of their position (487.00 shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $10.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2026ACC: 0001820885-26-000014
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-487.00
Net shares
Net seller
$10.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
487.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−487.00
Price / share
$22.00
Trade value
$10.71K
% of position
0.1%
7/1/2026
406.77K→406.29K
Total
Net shares
−487.00
Net value
-$10.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −487.00 | $22.00 | $10.71K | 0.1% | 406.77K | 406.29K |
| Total | −487.00 | -$10.71K | ||||||
Derivative Transactions0
No derivative transactions reported